# Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)

> **NCT00896181** · PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 26 (actual)

## Conditions studied

- Stage II Lymphoepithelioma of the Nasopharynx
- Stage II Squamous Cell Carcinoma of the Nasopharynx
- Stage III Lymphoepithelioma of the Nasopharynx
- Stage III Squamous Cell Carcinoma of the Nasopharynx
- Stage IV Lymphoepithelioma of the Nasopharynx
- Stage IV Squamous Cell Carcinoma of the Nasopharynx

## Interventions

- **DRUG:** docetaxel
- **DRUG:** cisplatin
- **DRUG:** carboplatin
- **DRUG:** fluorouracil
- **RADIATION:** 3-dimensional conformal radiation therapy
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT00896181
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-10
- **Primary completion:** 2020-01-03
- **Final completion:** 2020-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2021-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00896181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00896181, "Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00896181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*